 BEDFORD, Mass.--BUSINESS WIRE--- OCUL OCUTX--Ocular Therapeutix, Inc. NASDAQ:OCUL, a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that its application for the creation of a Category I Current Procedural Terminology CPT procedure code, presented at the October 2020 American Medical Association AMA CPT Editorial Panel Panel meeting, has been granted. The Panel has accepted the a 